Pinnacle Wealth Planning Services Inc. Sells 76 Shares of STERIS plc (NYSE:STE)

Pinnacle Wealth Planning Services Inc. lowered its stake in STERIS plc (NYSE:STE) by 5.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,318 shares of the medical equipment provider’s stock after selling 76 shares during the quarter. Pinnacle Wealth Planning Services Inc.’s holdings in STERIS were worth $271,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Geode Capital Management LLC lifted its position in STERIS by 0.7% in the third quarter. Geode Capital Management LLC now owns 2,303,625 shares of the medical equipment provider’s stock valued at $556,786,000 after purchasing an additional 17,007 shares during the last quarter. Principal Financial Group Inc. lifted its position in STERIS by 0.5% in the fourth quarter. Principal Financial Group Inc. now owns 1,119,643 shares of the medical equipment provider’s stock valued at $230,160,000 after purchasing an additional 5,419 shares during the last quarter. Raymond James Financial Inc. bought a new stake in STERIS in the fourth quarter valued at approximately $223,987,000. Franklin Resources Inc. lifted its position in STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after purchasing an additional 529,308 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of STERIS by 3.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 569,837 shares of the medical equipment provider’s stock valued at $117,136,000 after acquiring an additional 18,384 shares in the last quarter. Institutional investors own 94.69% of the company’s stock.

STERIS Price Performance

STE opened at $233.02 on Friday. The stock has a fifty day simple moving average of $216.96 and a two-hundred day simple moving average of $222.85. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The company has a market cap of $22.89 billion, a price-to-earnings ratio of 49.47 and a beta of 0.92. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts predict that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be issued a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 0.98%. STERIS’s dividend payout ratio (DPR) is 48.41%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on STE shares. Needham & Company LLC restated a “hold” rating on shares of STERIS in a report on Friday, November 8th. Stephens restated an “overweight” rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. Piper Sandler upped their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.